Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by skyhigh123on Jul 11, 2018 6:42pm
328 Views
Post# 28302961

RE:RE:Crazy volume

RE:RE:Crazy volume I really have no idea why the company would respond to the volume. When seeking Alpha posted that sh@t as@ company posted that bull sh@t article Prometic responded because of lies but today was different no leaks just plain speculation, In talks with 5 Big Pharmaceutical Companies wanting ( Block Buster Drugs With Absolutely No Adverse Side Affects ) Well we are at the point of is it really going to happen or not . Science says yes other wise why would they be negotiating with Prometic. The shorts well they have been in charge and there’s no denying that but but But is it in there Control  now ??? 
Sky
Bullboard Posts